| The repertoire of mutational signatures in human cancer LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AW Tian Ng, Y Wu, ... Nature 578 (7793), 94-101, 2020 | 2949 | 2020 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2557* | 2020 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2428 | 2018 |
| Patterns of somatic structural variation in human cancer genomes Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ... Nature 578 (7793), 112-121, 2020 | 825 | 2020 |
| Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortes-Ciriano, JK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... Nature Genetics 52, 331–341, 2020 | 660 | 2020 |
| A molecular portrait of microsatellite instability across multiple cancers I Cortes-Ciriano, S Lee, WY Park, TM Kim, PJ Park Nature communications 8 (1), 15180, 2017 | 636 | 2017 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 584 | 2020 |
| Mechanisms and therapeutic implications of hypermutation in gliomas M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ... Nature 580 (7804), 517-523, 2020 | 562 | 2020 |
| Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ... Nature genetics 52 (3), 306-319, 2020 | 403 | 2020 |
| Perspective on oncogenic processes at the end of the beginning of cancer genomics L Ding, MH Bailey, E Porta-Pardo, V Thorsson, A Colaprico, D Bertrand, ... Cell 173 (2), 305-320. e10, 2018 | 403 | 2018 |
| The landscape of viral associations in human cancers M Zapatka, I Borozan, DS Brewer, M Iskar, A Grundhoff, M Alawi, N Desai, ... Nature genetics 52 (3), 320-330, 2020 | 379 | 2020 |
| Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ... Nature communications 10 (1), 2674, 2019 | 358* | 2019 |
| Genomic basis for RNA alterations in cancer PCAWG Transcriptome Core Group Calabrese Claudia 2 Davidson Natalie R. 3 4 5 ... Nature 578 (7793), 129-136, 2020 | 304 | 2020 |
| Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet A Bender, I Cortés-Ciriano Drug discovery today 26 (2), 511-524, 2021 | 277 | 2021 |
| Detecting the mutational signature of homologous recombination deficiency in clinical samples DC Gulhan, JJK Lee, GEM Melloni, I Cortés-Ciriano, PJ Park Nature genetics 51 (5), 912-919, 2019 | 276 | 2019 |
| Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network MJ McConnell, JV Moran, A Abyzov, S Akbarian, T Bae, I Cortes-Ciriano, ... Science 356 (6336), eaal1641, 2017 | 265 | 2017 |
| Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer KC Akdemir, VT Le, S Chandran, Y Li, RG Verhaak, R Beroukhim, ... Nature genetics 52 (3), 294-305, 2020 | 249 | 2020 |
| Reconstructing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms D Van Egeren, J Escabi, M Nguyen, S Liu, CR Reilly, S Patel, B Kamaz, ... Cell stem cell 28 (3), 514-523. e9, 2021 | 196 | 2021 |
| A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns W Jiao, G Atwal, P Polak, R Karlic, E Cuppen, A Danyi, J de Ridder, ... Nature communications 11 (1), 728, 2020 | 193 | 2020 |
| Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis J Carlevaro-Fita, A Lanzós, L Feuerbach, C Hong, D Mas-Ponte, ... Communications biology 3 (1), 56, 2020 | 187 | 2020 |